Ticagrelor

FDA Approved: * September 4, 2018
Pharm Company: * WATSON LABS
Category: Heart (Cardiac)

Ticagrelor, sold under the brand name Brilinta among others, is a medication used for the prevention of stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coronary arteries. It acts as a platelet aggregation inhibitor by antagonising the P2Y12 receptor.[1] The drug is produced by AstraZeneca. 90mg tablet of Brilinta It was approved for medical use in the European Union in December 2010,[2]&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
5 Discussions

Dosage List

Ticagrelor
NDC: 48792-7864
Labeler:
Sunshine Lake Pharma Co., Ltd.
Ticagrelor
NDC: 48792-7898
Labeler:
Sunshine Lake Pharma Co., Ltd.
Ticagrelor 90 mg Oral Tablet
NDC: 69238-1134
Labeler:
Amneal Pharmaceuticals LLC

Related Brands

Drugs with the same active ingredients

Popular Topics

Ticagrelor, Breathlessness

My father suffered from a heart attack 3 weeks ago and now they put him on Ticagrelor 90mg twice daily. Up until having ...

2 REPLIES
Ticagrelor and OxyContin

Is it ok to take Ticagrelor (Brilinta) 90 mg and OxyContin together? ## According to the NIH I am not seeing any interac...

1 REPLY